SpaceX (SPCX) beat both revenue and EPS after Tuesday close — and dropped -7.46% after-hours to $115.98 on FY28 capex guide of $118.4B
Eli Lilly (LLY) reports this morning; consensus EPS $6.55, options priced for a 6.9% single-session move
JOLTS June came in at 7.36M openings vs 7.4M expected; Fed hike odds for September sit near 50% into Friday's payrolls
10-year yield holding near 4.67%; AMD reports after close tonight; SPCX 911.5M share unlock lands Thursday morning

• SpaceX beat Q2 revenue and posted a smaller loss than expected, then declined 7.46% after hours on FY28 capex guidance of $118.4 billion. Wall Street is now punishing high capex without matching execution. See Theme 1.

• The pattern from the past two weeks is clear: Amazon and Microsoft got paid for capex + execution. Meta and SpaceX got sold for capex alone. The rotation is at the ticker level, not the sector level. See Theme 2.

• Eli Lilly reports this morning with consensus EPS around $6.55 and options pricing a 6.9% swing. If you hold XLV or a healthcare sleeve, this print rolls straight through your Wednesday close. See Theme 3.

• JOLTS came in slightly below consensus at 7.36 million openings but the internals were mixed. September hike odds hover near 50%. Friday's payroll print is where the trade actually resolves. See Theme 4.

• Tomorrow morning: SpaceX's first insider-share unlock releases up to 911.5 million shares — roughly $103 billion in supply at current prices. Whatever the tape does today, Thursday is when actual price discovery happens. See Theme 5.

SpaceX beat every number Wall Street had estimated for its first-ever public quarterly last night. Revenue landed at $6.81 billion. The loss came in at nine cents per share against consensus for a twenty-four cent loss. Regular session Tuesday closed up 9.43% at $125.33. And then the after-hours session opened, digested the FY28 capex guide of $118.4 billion, and marked the stock down 7.46% to $115.98. That is a company that beat and got punished. It is also the third such print in three weeks — Meta and, on some readings, Microsoft's initial reaction — and it tells you what the tape is actually pricing right now. The bar this earnings season is not revenue. It is capex per dollar of proven execution. The map for today is below.

SpaceX's Q2 print was a genuine beat by every standard measure. Revenue $6.81 billion, matching the $6.82 billion consensus. Loss of nine cents per share versus expected loss of twenty-four cents, a beat by roughly 60%. Adjusted EBITDA came in near $2.0 billion. Musk's letter to shareholders raised the timeline for reaching $1 trillion in annual revenue to 2030 — a full year ahead of previous guidance — with a "non-zero chance" of hitting the mark in 2029. On any earlier earnings cycle, that would have been a clean twelve-percent-up print. Instead, the after-hours session marked the stock down 7.46% because the same shareholder letter guided fiscal-2028 capex to $118.4 billion, up from $48.7 billion this year.

The reason this matters for a retiree portfolio is that the market has quietly moved the goalposts for what an "AI-adjacent" earnings beat has to look like. Revenue beats no longer clear the bar on their own. What the tape now wants is revenue growth plus capex discipline plus proof that the capex being spent is producing returns. Amazon's AWS +37% cleared that bar. Microsoft's Azure execution cleared it. Meta's revenue growth without matching capex-return proof did not clear it. SpaceX's beat with a capex ramp did not clear it. The pattern is now consistent enough across four prints that it is not noise. It is the new pricing framework, and any stock you hold that is about to report AI-adjacent numbers is being read against this template.

Actionable Trade Setup

• Watching: SPCX into today's open and through Thursday's unlock; META, GOOG for read-across; AMD after close tonight against the same template.

• Bias: Neutral direct SPCX; awareness-only for index-holders through Thursday's unlock resolution.

• Risk note: if AMD tonight beats revenue but guides capex higher without execution proof, expect a similar after-hours sell response — and Nasdaq broader pressure Thursday morning.

The four-print pattern of the past two weeks does not just punish the losers. It creates a specific rotation, and the beneficiary is the second-order infrastructure name. If the market is going to reward AWS execution and punish SpaceX capex, both readings still assume the actual dollars are being spent on data centers, power, cooling, and short-haul transmission. Microsoft's fiscal-2027 capex guidance stepped up to $255-260 billion. Amazon's AWS growth of 37% implies its own capex step-up will follow. Add SpaceX's $118.4 billion FY28 guide, and hyperscaler-plus-infrastructure capex is now tracking toward $800-plus billion annually. That entire flow lands in the same set of companies regardless of which spender the tape is rewarding this week.

The names are the ones we discussed a week ago: NextEra Energy, Quanta Services, MasTec, Vertiv, Eaton. They are boring in a very specific and deliberate way — they build the physical infrastructure that everyone else's AI story requires. What has changed in the past week is that the case for owning them has strengthened, not weakened. The tape is now doing the discrimination job at the hyperscaler level. Below that, the money still has to be spent. Retirees who own these names indirectly through utility or S&P infrastructure ETFs (XLU, PAVE) are getting exposure that keeps working across both winners and losers of the capex debate.

Actionable Trade Setup

• Watching: NEE, PWR, MTZ, VRT, ETN into today's open; XLU and PAVE for the ETF-level positioning.

• Bias: Bullish structural on infrastructure-tier names. The capex debate at the hyperscaler level does not change the fact that the capex still has to physically land in these companies' order books.

• Risk note: if the broader Nasdaq weakens on Thursday's SPCX unlock, infrastructure names may sympathy-sell in the first hour. That is a buying window, not the trade thesis breaking.

Eli Lilly reports Q2 results before this morning's open. Consensus EPS sits at approximately $6.55. Options markets are pricing a 6.9% single-session move on the print — unusually wide for a mega-cap healthcare name, which reflects both the growth-versus-competition question in the weight-loss category and the sheer weight LLY carries inside the S&P 500 Health Care sector. Lilly is the single largest position in XLV and one of the top-weighted names in almost every broad healthcare index product a retiree portfolio might hold. A seven percent single-session move in LLY drags the whole ETF, drags the whole sector reading in target-date funds, and can push into broader-market indexes given LLY's overall S&P weight.

What the tape is really pricing into the print is the trajectory question, not the current quarter. Weight-loss drugs are on pace to generate roughly $13 billion in the quarter alone. Does the market keep expanding at the 2024-2025 pace, or does Novo Nordisk's competitive response plus emerging generic-adjacent alternatives compress Lilly's pricing power? Management will guide against that framework. If the guidance holds the trajectory, XLV holders participate in the upside. If the guidance suggests peak pricing power has arrived, a lot of retirees who wandered into "safe healthcare" are about to learn how much of their sleeve is actually one name.

Actionable Trade Setup

• Watching: LLY at open; XLV and target-date funds for concentration passthrough; NVO for competitive read.

• Bias: Neutral into print; concentration-awareness for ETF holders. Not a "buy or sell Lilly" question. A "how much of my healthcare exposure is actually Lilly" question, checked before the print, not after.

• Risk note: LLY is heavy enough in the S&P that a 7% move contributes to broader-index direction. Position that fact into any planned Wednesday sleeve trims.

🔒 OBBBA Rule Watch: Tax Rule of the Day

Rule 15: The HSA Triple-Tax Advantage

Health Savings Accounts are the only account in the U.S. tax code that gives you three tax advantages in one vehicle: contributions are tax-deductible on the way in, growth is tax-free while inside, and withdrawals for qualified medical expenses are tax-free on the way out. Under OBBBA, the HSA contribution limits for 2026 sit at $4,300 for self-only coverage and $8,550 for family coverage, with an additional $1,000 catch-up contribution allowed for account holders age 55 and older. Unlike a Flexible Spending Account, HSA balances roll over year after year and can be invested, meaning a disciplined HSA holder can build a six-figure account that functions as a dedicated healthcare-cost sleeve inside their overall retirement plan. After age 65, HSA withdrawals used for non-medical expenses are taxed as ordinary income (no penalty), which effectively converts an HSA into a second traditional-IRA-style account with a healthcare escape hatch.

Why it matters: If the weight-loss drug category continues at current prices, out-of-pocket healthcare costs for retirees will keep rising. An HSA is the one tax-preferred vehicle that lets you save for that cost with pre-tax dollars, grow the balance untaxed, and spend it untaxed. For a household that is HDHP-eligible and has not maxed out the account, this is the highest-return tax move available to a retiree that has not been closed by rate changes.

JOLTS came in at 7.36 million June job openings against consensus of 7.4 million. That is a small miss. The May revision brought that month's opening figure to 7.54 million. On the surface, this is dovish data — fewer openings suggest cooling labor demand and lower urgency for a Fed hike. But the internals were split. Hiring strengthened even as openings fell, which is the pattern of a labor market where employers are converting existing job listings to actual hires rather than posting new ones. That is not the same signal as a genuinely weakening labor market, and Fed hawks will read it that way. September hike odds barely moved on the release — still hovering near fifty percent according to fed funds futures.

What this means for the bond side of your portfolio through the rest of the week is that Friday's payroll print remains the resolving data point. A payroll number below 60,000 with an unemployment tick to 4.4% takes the September hike off the table. A payroll above 130,000 with unemployment steady at 4.3% pushes odds back above 60%. Anywhere in between and the ambiguity persists into Jackson Hole later this month. What this means for your IRA: the 10-year at 4.67% is priced for the ambiguity to resolve toward hawkish, not toward dovish. A dovish resolution is not free money for long-duration — it is a compression trade. Sized as duration management, not as directional bet.

Actionable Trade Setup

• Watching: TLT, IEF, HYG into Friday's 8:30 AM ET payroll release.

• Bias: Defensive long-duration; short-duration constructive; floating-rate income sleeve holds.

• Risk note: single data-point resolution is a two-sided trade. Any duration position sized as a directional bet on Friday is asymmetric against you.

Tomorrow morning, SpaceX's first insider-share unlock releases up to 911.5 million shares — roughly $103 billion of supply at current prices, and more than doubling the public float overnight. Post-IPO unlock events at this scale have historically produced single-session moves of five to fifteen percent independent of company fundamentals, because the pure supply expansion overwhelms any real-time price discovery. The direction of that move usually amplifies whatever the previous session established. SPCX went into today's open down 7.46% after-hours from its earnings print. Thursday's unlock, coming after Wednesday's regular session, will do whatever Wednesday sets it up to do — only more so. This is the day to be a spectator, not a participant.

Actionable Trade Setup

• Watching: SPCX into today's close; SSPC and SPCQ (inverse ETFs) for pressure signals.

• Bias: Awareness only. Sleeve consideration for anyone with meaningful direct SPCX exposure.

• Risk note: attempting to trade the unlock without a pre-established position is chasing supply that already priced in. Post-unlock stabilization typically takes three to five sessions.

For informational purposes only. Not investment advice. Past performance is not indicative of future results. Bastion Stability is a daily defensive briefing for retirees and pre-retirees and does not provide individualized tax or investment advice; consult a licensed advisor before making any decision relating to your retirement accounts.